The vaccine for human papillomavirus (HPV) is recommended in the United States for all young people up to age 26 to help prevent certain deadly cancers.

Using ipatasertib, researchers say some brain cancers could potentially be made vulnerable to immunotherapy agent

A team of researchers led by scientists at Tel Aviv University say they may have stumbled upon the “Achilles’ heel” of cancer cells, which could in the future lead to the development of an entirely new array of cancer drugs and treatments.

The future of cancer treatment might involve personalized vaccines meant to manage or even prevent relapses—at least if new research published Thursday continues to pan out. In a small clinical trial, high-risk melanoma patients given such a vaccine were able to create a long term, durable immune response to their cancer, scientists said. They also remained alive four years after the initial treatment, with most being actively disease-free.

The 10-year survival rate for cancer, once regarded as an incurable disease, has steadily been improving in Japan and if the cancer can be detected early enough, this survival rate increases further.

Scientists from the Tokyo University of Science say they have identified a polyphenolic compound found in blueberries called pterostilbene (PSB) with strong immunosuppressive properties. They believe it can provide a potential therapeutic option for chronic inflammatory diseases, including inflammatory bowel disease (IBD).

More than 200 genes with novel and known roles in glioblastoma – the most aggressive type of brain cancer – offer promising new drug targets. Researchers from the Wellcome Sanger Institute, Addenbrooke’s Hospital and their collaborators engineered a new mouse model to show for the first time how a mutation in the well-known cancer gene, EGFR initiates glioblastoma, and works with a selection from more than 200 other genes to drive the cancer.

Sitting for hours on end could heighten someone's risk of later dying from cancer, according to a sobering new study of the relationship between inactivity and cancer mortality. The study was epidemiological, providing a snapshot of people's lives, so it cannot prove cause and effect. But the findings suggest that extremely sedentary people can be as much as 80 per cent more likely to die of cancer than those who sit the least.

Aspirin is associated with a reduction in the risk of developing several cancers of the digestive tract, including some that are almost invariably fatal, such as pancreatic and liver cancers. The largest and most comprehensive analysis to date of the link between aspirin and digestive tract cancers found reductions in the risk of these cancers of between 22% and 38%.

Biomarkers are biological signatures in the body that can indicate the presence of cancer. A promising source of new biomarkers are extracellular vesicles. These are microscopic vesicles that are released by cancer cells into biological fluids, such as urine. Detecting and examining these vesicles in urine has an enormous potential for developing new tests for early detection of urological cancers. However, research related to this is still in its infancy, says Bert Dhondt from Ghent University.

California requires Proposition 65 cancer warnings on hundreds of products, ranging from tobacco and gasoline to beer and french fries. But there are no warnings on processed meats, like hot dogs, corned beef and bacon, despite an international agency’s findings in 2015 that those foods cause cancer in humans.

- Peto's Paradox

Research into genetic mutations suggests possibility of tests that would detect cancer earlier

A controversial new study claims about one in every five cancers diagnosed in Australia would have been better left undiscovered.

A newly-discovered part of our immune system could be harnessed to treat all cancers, say scientists. The Cardiff University team discovered a method of killing prostate, breast, lung and other cancers in lab tests. The findings, published in Nature Immunology, have not been tested in patients, but the researchers say they have "enormous potential".

The move toward targeted anti-cancer treatments has produced better outcomes with fewer side-effects for many breast cancer patients. But so far, advances in precision medicine haven’t reached people diagnosed with so-called triple-negative breast cancer.

British scientists may have discovered a cure for cancer — by accident. As The Telegraph reports, “Researchers at Cardiff University were analyzing blood from a bank in Wales, looking for immune cells that could fight bacteria, when they found an entirely new type of T-cell. That new immune cell carries a never-before-seen receptor which acts like a grappling hook, latching on to most human cancers, while ignoring healthy cells.”

Research is at an early stage but scientists said it had huge potential for destroying cancers.

“Deer antlers [are] using essentially a controlled form of bone cancer growth,” says Edward Davis, an evolutionary paleobiologist